<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03548753</url>
  </required_header>
  <id_info>
    <org_study_id>HM19501968</org_study_id>
    <nct_id>NCT03548753</nct_id>
  </id_info>
  <brief_title>Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score</brief_title>
  <acronym>FACC</acronym>
  <official_title>Functional and Anatomical Testing in Intermediate Risk Chest Pain Patients With Severe Coronary Calcium Score</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, blinded multicenter study for evaluation of chest pain patients with severe
      coronary calcium (Agatston score &gt; 399). The objective is to evaluate if an initial
      non-invasive strategy with coronary computed tomography angiography (CCTA) including
      functional flow reserve derived from CCTA (FFR-CT) is as effective as invasive coronary
      angiography (ICA) including functional flow reserve (FFR) for the detection and exclusion of
      obstructive coronary artery disease (CAD). Study hypothesis: initial non-invasive anatomic
      and functional testing is non-inferior to an invasive anatomic and functional testing
      strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, blinded multicenter study evaluating the diagnostic performance of coronary
      computed tomography angiography (CCTA) including functional flow reserve derived from CCTA
      (FFR-CT) for the detection and exclusion of significant obstructive coronary artery disease
      (CAD). The reference standard vil be invasive coronary angiography (ICA) including functional
      flow reserve (FFR). Patients referred for elective CCTA because of suspected stable CAD are
      considered. If the initial routine non-enhanced CT scan shows an Agatston score &gt; 399, the
      patient is eligible for study inclusion. Four sites in the region of Southern Denmark will
      participate (Odense University Hospital, Svendborg Hospital, Vejle Hospital and Esbjerg
      Hospital). A total of 278 patients will be included.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2, 2016</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Per-patient diagnostic accuracy of functional flow reserve (FFR-CT) derived from standard coronary computed tomography angiography (CCTA) compared to invasive coronary angiography (ICA) including functional flow ratio (FFR)</measure>
    <time_frame>Comparison of the noninvasive and invasive diagnostic modalities is performed at least 90 days after enrollment of each of the included patients</time_frame>
    <description>The primary outcome measure is the per-patient diagnostic accuracy of functional flow reserve (FFR-CT) derived from standard coronary computed tomography angiography (CCTA) compared to invasive coronary angiography (ICA) including functional flow ratio (FFR), which is considered the gold standard in the detection or exclusion of obstructive coronary artery disease (CAD)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Invasive coronary angiography (ICA) including functional flow ratio (FFR) without obstructive coronary artery disease</measure>
    <time_frame>90 days after inclusion</time_frame>
    <description>Percentage of patients with invasive coronary angiography (ICA) including functional flow reserve (FFR) measurement without evidence of obstructive coronary artery disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary revascularization procedures</measure>
    <time_frame>90 day after inclusion</time_frame>
    <description>Percentage of coronary revascularization procedures (PCI and CABG) in patients with reduced FFR-CT vs. patients with normal FFR-CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other clinical endpoints</measure>
    <time_frame>90 days after inclusion</time_frame>
    <description>Percentage of patients with the composite endpoint of all-cause mortality or myocardial infarction or unstable angina hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major complications from diagnostic invasive diagnostic procedures</measure>
    <time_frame>Within 72 hours after invasive procedure</time_frame>
    <description>Percentage of patients with major complications following invasive coronary angiography (ICA) including fractional flow reserve (FFR) measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per-patient and per-vessel diagnostic performance of FFR-CT by means of accuracy, sensitivity, specificity, positive predictive value, and negative predictive value</measure>
    <time_frame>At least 90 days after patient inclusion</time_frame>
    <description>Assessing per-patient and per-vessel diagnostic performance of FFR-CT by means of accuracy, sensitivity, specificity, positive predictive value, and negative predictive value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per-vessel correlation of FFR-CT numerical value with the FFR numerical value in patients undergoing FFR</measure>
    <time_frame>At least 90 days after patient inclusion</time_frame>
    <description>The per-vessel correlation of FFRCT numerical value with the FFR numerical value in patients undergoing FFR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The diagnostic accuracy of FFR-CT in subgroups of patients with high calcium score vs. patients with very high calcium score</measure>
    <time_frame>At least 90 days after patient inclusion</time_frame>
    <description>Comparison of the diagnostic accuracy of FFR-CT in subgroups of patients with high calcium score (Agatston score 400-999) vs patients with very high calcium score (Agatston score ≥ 999)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs and resource use.</measure>
    <time_frame>90 days after inclusion</time_frame>
    <description>Estimating the total costs of potentially unnecessary invasive coronary angiographies with functional flow ratio measurements</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">278</enrollment>
  <condition>Observational</condition>
  <arm_group>
    <arm_group_label>Patients with Agatston score &gt; 399</arm_group_label>
    <description>Coronary computed tomography angiography with FFR-CT
Invasive coronary angiography with FFR</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Clinical stable outpatients with symptoms of suspected coronary artery disease (CAD)
        referred for coronary computed tomography angiography (CCTA) as first-line noninvasive
        diagnostic test at one of the four participating centers are eligible for study inclusion,
        if the initial routine non-enhanced CT scan shows an Agatston score &gt; 399.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  An estimated likelihood for the presence of significant CAD between 15% and 85%

          -  Clinical stable patients with symptoms of suspected CAD referred for CTTA

          -  Initial routine non-enhanced CT scan shows an Agatston score &gt;399

          -  Written informed consent

          -  Accept to undergo elective invasive coronary angiography (ICA) within 90 days

        Exclusion Criteria:

          -  Known prior myocardial infarction

          -  Prior percutaneous coronary intervention (PCI)

          -  Prior coronary artery bypass surgery (CABG)

          -  Pacemaker or internal defibrillator lead implantation

          -  Prosthetic heart valve

          -  Atrial fibrillation

          -  Renal Insufficiency (&lt;40 mL/min)

          -  Known anaphylactic reaction to iodinated contrast

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hans Mickley, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor, MD, DMSc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <state>Odense C</state>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Lu MT, Ferencik M, Roberts RS, Lee KL, Ivanov A, Adami E, Mark DB, Jaffer FA, Leipsic JA, Douglas PS, Hoffmann U. Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. JACC Cardiovasc Imaging. 2017 Nov;10(11):1350-1358. doi: 10.1016/j.jcmg.2016.11.024. Epub 2017 Apr 12.</citation>
    <PMID>28412436</PMID>
  </reference>
  <reference>
    <citation>Patel MR, Dai D, Hernandez AF, Douglas PS, Messenger J, Garratt KN, Maddox TM, Peterson ED, Roe MT. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J. 2014 Jun;167(6):846-52.e2. doi: 10.1016/j.ahj.2014.03.001. Epub 2014 Mar 14.</citation>
    <PMID>24890534</PMID>
  </reference>
  <reference>
    <citation>Yan RT, Miller JM, Rochitte CE, Dewey M, Niinuma H, Clouse ME, Vavere AL, Brinker J, Lima JA, Arbab-Zadeh A. Predictors of inaccurate coronary arterial stenosis assessment by CT angiography. JACC Cardiovasc Imaging. 2013 Sep;6(9):963-72. doi: 10.1016/j.jcmg.2013.02.011. Epub 2013 Aug 8.</citation>
    <PMID>23932641</PMID>
  </reference>
  <reference>
    <citation>Kruk M, Noll D, Achenbach S, Mintz GS, Pręgowski J, Kaczmarska E, Kryczka K, Pracoń R, Dzielińska Z, Sleszycka J, Witkowski A, Demkow M, Rużyłło W, Kępka C. Impact of coronary artery calcium characteristics on accuracy of CT angiography. JACC Cardiovasc Imaging. 2014 Jan;7(1):49-58. doi: 10.1016/j.jcmg.2013.07.013. Epub 2013 Nov 27.</citation>
    <PMID>24290567</PMID>
  </reference>
  <reference>
    <citation>Ong TK, Chin SP, Liew CK, Chan WL, Seyfarth MT, Liew HB, Rapaee A, Fong YY, Ang CK, Sim KH. Accuracy of 64-row multidetector computed tomography in detecting coronary artery disease in 134 symptomatic patients: influence of calcification. Am Heart J. 2006 Jun;151(6):1323.e1-6.</citation>
    <PMID>16781246</PMID>
  </reference>
  <reference>
    <citation>Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, Dunning A, DeFrance T, Lansky A, Leipsic J, Min JK. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 2011 Nov 1;58(19):1989-97. doi: 10.1016/j.jacc.2011.06.066.</citation>
    <PMID>22032711</PMID>
  </reference>
  <reference>
    <citation>Nørgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Bøtker HE, Achenbach S; NXT Trial Study Group. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol. 2014 Apr 1;63(12):1145-1155. doi: 10.1016/j.jacc.2013.11.043. Epub 2014 Jan 30.</citation>
    <PMID>24486266</PMID>
  </reference>
  <reference>
    <citation>Nørgaard BL, Gaur S, Leipsic J, Ito H, Miyoshi T, Park SJ, Zvaigzne L, Tzemos N, Jensen JM, Hansson N, Ko B, Bezerra H, Christiansen EH, Kaltoft A, Lassen JF, Bøtker HE, Achenbach S. Influence of Coronary Calcification on the Diagnostic Performance of CT Angiography Derived FFR in Coronary Artery Disease: A Substudy of the NXT Trial. JACC Cardiovasc Imaging. 2015 Sep;8(9):1045-1055. doi: 10.1016/j.jcmg.2015.06.003. Epub 2015 Aug 19.</citation>
    <PMID>26298072</PMID>
  </reference>
  <reference>
    <citation>Hecht HS. Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc Imaging. 2015 May;8(5):579-596. doi: 10.1016/j.jcmg.2015.02.006. Review.</citation>
    <PMID>25937196</PMID>
  </reference>
  <reference>
    <citation>Douglas PS, Hoffmann U, Lee KL, Mark DB, Al-Khalidi HR, Anstrom K, Dolor RJ, Kosinski A, Krucoff MW, Mudrick DW, Patel MR, Picard MH, Udelson JE, Velazquez EJ, Cooper L; PROMISE investigators. PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. Am Heart J. 2014 Jun;167(6):796-803.e1. doi: 10.1016/j.ahj.2014.03.003. Epub 2014 Mar 18.</citation>
    <PMID>24890527</PMID>
  </reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 22, 2018</study_first_submitted>
  <study_first_submitted_qc>June 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2018</study_first_posted>
  <last_update_submitted>June 13, 2018</last_update_submitted>
  <last_update_submitted_qc>June 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Hans Mickley</investigator_full_name>
    <investigator_title>Professor (chair), MD</investigator_title>
  </responsible_party>
  <keyword>Angina</keyword>
  <keyword>Chest pain</keyword>
  <keyword>Diagnostic tests</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

